← Browse by Condition
Medical Condition
amnestic mild cognitive impairment
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for amnestic mild cognitive impairment sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05446584 Phase 2
Recruiting
Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History
Enrollment
75 pts
Location
United States
Sponsor
University of Texas Southweste...
NCT04240561
Recruiting
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
Enrollment
20 pts
Location
United States
Sponsor
Northwestern University
NCT05903573
Recruiting
Training Response Artificial Intelligence Network (TRAIN)
Enrollment
75 pts
Location
United States
Sponsor
University of Florida
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology